Ok Biotech Co Ltd (4155) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.100x

Based on the latest financial reports, Ok Biotech Co Ltd (4155) has a cash flow conversion efficiency ratio of 0.100x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$256.86 Million ≈ $8.09 Million USD) by net assets (NT$2.58 Billion ≈ $81.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ok Biotech Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Ok Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Ok Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ok Biotech Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Ok Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ok Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GreenMobility A/S CO:GREENM	0.802x
Alpha Pro Tech Ltd NYSE MKT:APT	0.000x
SLP Resources Bhd KLSE:7248	0.017x
abrdn Asia Pacific Income Fund VCC TO:FAP	-0.049x
Oriola-KD Oyj A HE:OKDAV	0.229x
IMPACT Silver Corp. V:IPT	-0.016x
DCM Corp KO:024090	0.019x
CONCORD ENVIRO SYSTEMS L NSE:CEWATER	-0.074x

Annual Cash Flow Conversion Efficiency for Ok Biotech Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Ok Biotech Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.58 Billion ≈ $81.16 Million	NT$319.57 Million ≈ $10.07 Million	0.124x	+383.18%
2024-12-31	NT$2.57 Billion ≈ $80.87 Million	NT$65.90 Million ≈ $2.08 Million	0.026x	+1996.54%
2023-12-31	NT$2.40 Billion ≈ $75.46 Million	NT$2.93 Million ≈ $92.41K	0.001x	-99.06%
2022-12-31	NT$1.85 Billion ≈ $58.17 Million	NT$240.53 Million ≈ $7.58 Million	0.130x	+913.18%
2021-12-31	NT$1.70 Billion ≈ $53.65 Million	NT$21.90 Million ≈ $689.84K	0.013x	-84.86%
2020-12-31	NT$1.74 Billion ≈ $54.79 Million	NT$147.70 Million ≈ $4.65 Million	0.085x	+144.78%
2019-12-31	NT$1.30 Billion ≈ $41.02 Million	NT$45.18 Million ≈ $1.42 Million	0.035x	-65.83%
2018-12-31	NT$1.27 Billion ≈ $39.95 Million	NT$128.75 Million ≈ $4.06 Million	0.102x	+19.16%
2017-12-31	NT$1.21 Billion ≈ $38.00 Million	NT$102.77 Million ≈ $3.24 Million	0.085x	-69.12%
2016-12-31	NT$944.80 Million ≈ $29.77 Million	NT$260.72 Million ≈ $8.21 Million	0.276x	-9.41%
2015-12-31	NT$950.15 Million ≈ $29.94 Million	NT$289.44 Million ≈ $9.12 Million	0.305x	+864.81%
2014-12-31	NT$849.48 Million ≈ $26.76 Million	NT$-33.83 Million ≈ $-1.07 Million	-0.040x	-127.88%
2013-12-31	NT$609.65 Million ≈ $19.21 Million	NT$87.08 Million ≈ $2.74 Million	0.143x	-18.43%
2012-12-31	NT$452.10 Million ≈ $14.24 Million	NT$79.17 Million ≈ $2.49 Million	0.175x	-42.99%
2011-12-31	NT$303.11 Million ≈ $9.55 Million	NT$93.12 Million ≈ $2.93 Million	0.307x	+463.30%
2010-12-31	NT$230.78 Million ≈ $7.27 Million	NT$-19.52 Million ≈ $-614.83K	-0.085x	-247.52%
2009-12-31	NT$121.25 Million ≈ $3.82 Million	NT$6.95 Million ≈ $218.96K	0.057x	--

About Ok Biotech Co Ltd

TW:4155 Taiwan Medical Devices

Market Cap

$64.02 Million

NT$2.03 Billion TWD

Market Cap Rank

#20899 Global

#1251 in Taiwan

Share Price

NT$14.40

Change (1 day)

+0.00%

52-Week Range

NT$12.90 - NT$16.50

All Time High

NT$37.98